The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

Calcium channel blockers were linked to a marginally slower rate of visual field deterioration in glaucoma patients, though not clinically significant. The study involved a retrospective longitudinal ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

NEW YORK, July 31 (Praxis Press) Cardiovascular outcomes have not been compared in hypertensive patients treated with calcium channel blockers and in patients treated with older drugs. Hansson and ...

If you have an abnormal heart rhythm or another heart condition like high blood pressure, a beta-blocker may be a key part of your treatment plan. Beta-blockers, such as atenolol, metoprolol, and ...

Researchers at the University Medical Center Göttingen (UMG) have shown how a minimal change in a single ion channel increases the sensitivity of sensory cells in the inner ear. Even soft sounds, such ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the ...

Use of systemic calcium channel blockers (CCBs) are associated with a slower rate of visual field (VF) deterioration in patients with glaucoma, according to research published in Ophthalmology ...